Latest Breaking News On - Takanawa - Page 56 : comparemela.com

Tiziana seeks partner in Asia to enhance hepatocellular carcinoma treatment

Tiziana seeks partner in Asia to enhance hepatocellular carcinoma treatment Tiziana seeks partner in Asia to enhance hepatocellular carcinoma treatment 05 May 2021 | News Source credit: Shutterstock Tiziana Life Sciences plc, a UK based biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, announces that it has executed an agreement with Takanawa Japan KK, Pharma Team, for a strategic business development plan to identify a clinical partner in Japan and other Asian countries for further clinical development of Milciclib for treatment in advanced hepatocellular carcinoma (HCC) patients. Previously, Tiziana successfully completed a Phase 2 clinical trial with orally administered Milciclib in sorafenib-resistant or intolerant HCC patients. The clinical data, presented at the American Society of Clinical Oncology (ASCO), demonstrated that the treatment was well-tolerated and produced clinical activity. Recently, a patent co

United statesUnited kingdomTiziana life sciencesAmerican society of clinical oncologyPharma teamTakanawa japanAmerican societyClinical oncologyஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்அமெரிக்கன் சமூகம் ஆஃப் மருத்துவ புற்றுநோயியல்பார்மா அணிஅமெரிக்கன் சமூகம்மருத்துவ புற்றுநோயியல்

FTSE 100 keeps rising as recovery stocks and miners continue to provide support

Tetra Bio-Pharma Inc (TSE:TBP) (OTCMKTS:TBPMF) (FRA:JAM1) expects to generate over C$47.5M from DanCann Pharma distribution deal HighGold Mining Inc (CVE:HIGH) (OTCQX:HGGOF) plans at least 16,000 metres of drilling in Alaska this year as it approves C$10M exploration budget CytoDyn Inc (OTCQB:CYDY) strikes agreement with AEIH in Brazil to run two coronavirus trials using its flagship drug leronlimab 2.39pm: Wall Street opens higher after ADP jobs data The main indices on Wall Street opened on the front foot on Wednesday after the latest ADP jobs report showed a surge in private sector hiring in April, although less than analysts had expected.

New yorkUnited statesHong kongUnited kingdomSouth africaGreat dykeZimbabwe generalCity ofNorthern territoryGordons damWestern australiaSouth australiaSouth koreaMichael hewsonJanet yellenSophie griffiths

Tiziana Announces Strategic Initiative with Takanawa Japan

Tiziana Announces Strategic Initiative with Takanawa Japan K.K., Pharma Team, to Identify a Partner in Japan and Other Asian Countries for Further Clinical Development of Milciclib in Patients with Advanced Hepatocellular Carcinoma. Tiziana Life Sciences Plc London, UNITED KINGDOM Objective of this partnership with Takanawa Japan K.K., Pharma Team, is to identify a strategic partner in Japan for further development of Milciclib either alone or in combination with a tyrosine kinase inhibitor (TKI) for treatment of advanced HCC patients in Asian countries where prevalence of HCC is high, and the available therapeutic options are not entirely satisfactory. Milciclib, a broad-spectrum cyclin dependent kinase (pan-CDK) inhibitor, has successfully completed eight phase 1 and phase 2 trials in thymic carcinoma, thymoma and hepatocellular carcinoma (HCC), showing tolerability and positive clinical responses.

Pharma teamபார்மா அணி

ファンコミュニティ「Mechu(ミーチュー)」が新たに4つの拡張機能「ガチャアプリ」「デジタルコンテンツ販売アプリ」「無料プラン追加アプリ」「プラン追加・削除アプリ」を一挙リリース!

ファンコミュニティ「Mechu(ミーチュー)」が新たに4つの拡張機能「ガチャアプリ」「デジタルコンテンツ販売アプリ」「無料プラン追加アプリ」「プラン追加・削除アプリ」を一挙リリース!
sankei.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sankei.com Daily Mail and Mail on Sunday newspapers.

Circle officeFukushima officeSun tokyo officeGreen oak takanawaBook cornerSankei newsவட்டம் அலுவலகம்நூல் மூலையில்சங்கே செய்தி

SHIGERU AND CANNSUN ESTABLISH A JOINT VENTURE COMPANY AS EU GMP-BASED CBD PLATFORM IN JAPAN

Share This Article CAPE TOWN , SOUTH AFRICA , April 26, 2021 /EINPresswire.com/ Cannsun Group PLC ( Cannsun ), a bio-pharmaceutical company focused on developing and commercializing new medicines to optimize human potential with operations in South Africa, Greece, Japan, Thailand and Lesotho. Cannsun Group PLC is pleased to announce its establishment of its Joint Venture company with SHIGERU GmbH that has been established as Technology Transfer venture capital supported by Basel government of Switzerland, hereafter called “Shigeru”, headquarters in Tokyo Japan, and represented by Mr. Shigeru Shiraki. The Joint Venture company has been established as “Cannsun Medhel Japan Co. Ltd.” in Japan. The company will distribute Cannsun GMP products including pharmaceuticals, cosmetics & food supplements throughout Japan, China and other Asian countries. The new Joint Venture will develop additional R&D partnerships in Japan with a primary focus on oncology, depress

Shinagawa kuSouth africaShigeru shirakiKeiko horikawaGreg bealerCannsun medhel japan coCannsun groupJoint ventureTechnology transferTokyo japanMedhel japanShigeru japanKarolinska institutetGmp basedஷினகாவா குகூட்டு துணிகர